Page last updated: 2024-11-05

phenylacetylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Phenylacetylene is an organic compound with the formula C6H5C≡CH. It is a colorless liquid with a pungent odor. Phenylacetylene is a versatile building block in organic synthesis, used to prepare various compounds including pharmaceuticals, polymers, and agrochemicals. It can be synthesized through various methods, such as the reaction of phenylacetylene with sodium amide in liquid ammonia or the elimination of hydrogen bromide from phenylethyl bromide. Phenylacetylene is also an important intermediate in the production of polymers such as polyacetylene. Due to its unique structure and reactivity, phenylacetylene has been extensively studied for its potential applications in material science, catalysis, and organic synthesis. Its biological activity is also being investigated, particularly for its potential to inhibit the growth of cancer cells.'

phenylacetylene: can polymerize into DENDRIMERS [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10821
CHEMBL ID234833
CHEBI ID167069
MeSH IDM0130481

Synonyms (56)

Synonym
239wsr2ibo ,
unii-239wsr2ibo
EN300-19670
CHEBI:167069
536-74-3
acetylene, phenyl-
phenylethyne
1-phenylethyne
nsc-4957
nsc4957
phenylacetylide
benzene, ethynyl-
ethyne, phenyl-
wln: 1uu1r
phenylacetylene
ethynylbenzene
ai3-24180
einecs 208-645-1
nsc 4957
ethynyl-benzene (phenylacetylene)
phenylacethylene
inchi=1/c8h6/c1-2-8-6-4-3-5-7-8/h1,3-7
phenylacetylene, 98%
c8h6
1-ethynylbenzene
CHEMBL234833
AKOS000269051
E0196
phenyl acetylene
A829727
ethynyl-benzene
benzene, ethenyl-, trimer
FT-0626367
ethynyl-2-13c-benzene
ethynylbenzene [mi]
126716-66-3
phenylacetylen
ethynylbenzen
ethynyl benzene
1-phenylacetylene
1-ethynyl-benzene
phenyl-acetylene
ph-c=ch
DTXSID1060211
ethinylbenzene
ethynyl-d-benzene
J-802270
F0001-1393
phenylacetylene, purum, >=97.0% (gc)
mfcd00008570
phenylacetylene, ~98%
Q417321
AS-12473
AMY4006
D90456
120851-94-7

Research Excerpts

Effects

Phenylacetylene has a high solubility and low volatility. It may prove to be useful for monitoring methanotrophic and nitrifying activity as well as identifying the form of MMO predominantly expressed in situ.

ExcerptReferenceRelevance
"As phenylacetylene has a high solubility and low volatility, it may prove to be useful for monitoring methanotrophic and nitrifying activity as well as identifying the form of MMO predominantly expressed in situ."( Differential inhibition in vivo of ammonia monooxygenase, soluble methane monooxygenase and membrane-associated methane monoxygenase by phenylacetylene.
DiSpirito, AA; Hooper, AB; Krema, CL; Lontoh, S; Semrau, JD; Whittaker, MR, 2000
)
1.02
"Phenylacetylene has two possible pi hydrogen bonding acceptor sites (phenyl or acetylene) that compete for hydrogen bond donors in solution at room temperature."( Hydrogen bond migration between molecular sites observed with ultrafast 2D IR chemical exchange spectroscopy.
Fayer, MD; Gengeliczki, Z; Kwak, K; Rosenfeld, DE, 2010
)
1.08
"As phenylacetylene has a high solubility and low volatility, it may prove to be useful for monitoring methanotrophic and nitrifying activity as well as identifying the form of MMO predominantly expressed in situ."( Differential inhibition in vivo of ammonia monooxygenase, soluble methane monooxygenase and membrane-associated methane monoxygenase by phenylacetylene.
DiSpirito, AA; Hooper, AB; Krema, CL; Lontoh, S; Semrau, JD; Whittaker, MR, 2000
)
1.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
benzenesAny benzenoid aromatic compound consisting of the benzene skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Triterpenoid Biosynthesis1322

Bioassays (2)

Assay IDTitleYearJournalArticle
AID299150Growth inhibition of Verticillium lamellicola at 50 ug/mL2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
Design and synthesis of beta-methoxyacrylate analogues via click chemistry and biological evaluations.
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (162)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (2.47)18.7374
1990's2 (1.23)18.2507
2000's74 (45.68)29.6817
2010's73 (45.06)24.3611
2020's9 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.25 (24.57)
Research Supply Index5.11 (2.92)
Research Growth Index5.79 (4.65)
Search Engine Demand Index95.65 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.22%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other162 (98.78%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]